Literature DB >> 20463364

Targeting cell metabolism in cancer patients.

Matthew G Vander Heiden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20463364     DOI： 10.1126/scitranslmed.3001210

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


× No keyword cloud information.
  9 in total

Review 1.  Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.

Authors:  Siver Andreas Moestue; Olav Engebraaten; Ingrid Susann Gribbestad
Journal:  Mol Oncol       Date:  2011-04-23       Impact factor: 6.603

Review 2.  Therapeutic strategies impacting cancer cell glutamine metabolism.

Authors:  Michael J Lukey; Kristin F Wilson; Richard A Cerione
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

3.  Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer.

Authors:  Ashish Juvekar; Laura N Burga; Hai Hu; Elaine P Lunsford; Yasir H Ibrahim; Judith Balmañà; Anbazhagan Rajendran; Antonella Papa; Katherine Spencer; Costas A Lyssiotis; Caterina Nardella; Pier Paolo Pandolfi; José Baselga; Ralph Scully; John M Asara; Lewis C Cantley; Gerburg M Wulf
Journal:  Cancer Discov       Date:  2012-08-22       Impact factor: 39.397

4.  Case report: Sodium dichloroacetate (DCA) inhibition of the "Warburg Effect" in a human cancer patient: complete response in non-Hodgkin's lymphoma after disease progression with rituximab-CHOP.

Authors:  Stephen B Strum; Orn Adalsteinsson; Richard R Black; Dmitri Segal; Nancy L Peress; James Waldenfels
Journal:  J Bioenerg Biomembr       Date:  2012-12-20       Impact factor: 2.945

5.  S6K1 determines the metabolic requirements for BCR-ABL survival.

Authors:  J F Barger; C A Gallo; P Tandon; H Liu; A Sullivan; H L Grimes; D R Plas
Journal:  Oncogene       Date:  2012-03-05       Impact factor: 9.867

6.  Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia.

Authors:  Jinghan Wang; Wenle Ye; Xiao Yan; Qi Guo; Qiuling Ma; Fang Lin; Jiansong Huang; Jie Jin
Journal:  J Transl Med       Date:  2019-05-10       Impact factor: 5.531

Review 7.  Dysregulated metabolism contributes to oncogenesis.

Authors:  Matthew D Hirschey; Ralph J DeBerardinis; Anna Mae E Diehl; Janice E Drew; Christian Frezza; Michelle F Green; Lee W Jones; Young H Ko; Anne Le; Michael A Lea; Jason W Locasale; Valter D Longo; Costas A Lyssiotis; Eoin McDonnell; Mahya Mehrmohamadi; Gregory Michelotti; Vinayak Muralidhar; Michael P Murphy; Peter L Pedersen; Brad Poore; Lizzia Raffaghello; Jeffrey C Rathmell; Sharanya Sivanand; Matthew G Vander Heiden; Kathryn E Wellen
Journal:  Semin Cancer Biol       Date:  2015-10-08       Impact factor: 15.707

8.  The long and winding road to the mitochondrial pyruvate carrier.

Authors:  John C Schell; Jared Rutter
Journal:  Cancer Metab       Date:  2013-01-23

Review 9.  Dysbiosis of gut microbiota in promoting the development of colorectal cancer.

Authors:  Shaomin Zou; Lekun Fang; Mong-Hong Lee
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-10-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.